Factual background
5 On 15 April 2003 the respondent was sentenced by Simpson J in respect of two offences against Orders pursuant to the Stock Medicines Act 1989 (Commonwealth). The offences were wilfully supplying a quantity of injectable steroids for which the respondent was fined $3,000 and wilfully making a false entry in a record in relation to the steroids for which the respondent was fined $2,000. At the time of sentence the respondent was in practice as a veterinary surgeon.
6 On 4 November 2003 an email was sent to the respondent from a supplier in China providing details of the product Nandrolone Decanoate. On 10 November 2003 the respondent replied to that email and ordered 5 kgs of Nandrolone Decanoate for the price of $US1900 per kilogram. The email of 10 November 2003 included instructions as follows.
"You will have to relabel Nandrolone as Creatine Monohydrate or Glucosamine HCL as before. Still too much trouble with Customs costs (charge us $20 extra tax on invoice) etc. You can send me the invoice for Nandrolone separate later. Once you have air courier for Glucosamine plus Creatine, then you can fax me the invoice and airway bill, but please be sure there is no Nandrolone mentioned anywhere!"
7 On 1 December 2003 the respondent by telegraphic transfer sent the sum of $US10,500 to the supplier. On 11 December 2003 the supplier confirmed by email that the goods had been shipped. On 16 December 2003 the goods, the subject of the charge, arrived in Sydney from China on an Air New Zealand flight. On 17 December 2003 the imported substances were subjected to a covert examination by Australian Customs Service officers. The importer of the substances was nominated as Australian Racing Pharmaceuticals Pty Limited. The respondent was a director of that company but his co-director Mr Carmichael was completely unaware of the importation and it seems clear that the importation was not on behalf of the company but on behalf of the respondent personally.
8 An analysis of the goods by the Customs Service revealed that the substance incorrectly labelled as Glucosamine had a net weight of almost 5 kgs and contained an estimated 85.8% Nandrolone Decanoate.
9 On 24 December 2003 Customs officers executed a warrant on the respondent. A seizure notice was forwarded in respect of the 5 kgs drum of Nandrolone Decanoate.
10 It was common ground that the substance Nandrolone Decanoate is used for a variety of serious medical conditions and as such has a legitimate clinical application. The substance can also be used upon animals, in particular dogs and horses, and is frequently used for that purpose. It is used in veterinary medicine for convalescence and tissue repair following injury. It can improve appetite and mood in racing horses. The taking of Nandrolone, which is a steroid, can also enhance the athletic performance of human beings but can have significant adverse effects when taken by human beings. It is for this reason that its importation and export is strictly controlled in Australia.
11 Five kilograms of Nandrolone Decanoate is a large quantity. There was expert evidence that such a quantity would equate to at least 10,000 equine doses. There was also evidence (the precise amount was disputed by the respondent) that such a quantity of Nandrolone Decanoate would have a potential resale value in Australia significantly higher than its cost of purchase being in the order of $200,000.
12 In about August 2004 the respondent was deregistered as a veterinary surgeon. The basis for that deregistration was the conviction for the offences dealt with by Simpson J and the respondent's plea of guilty to this offence. Not surprisingly the respondent has suffered economic loss as a result of his deregistration as a veterinary surgeon.
13 The respondent entered a plea of guilty to the charge in the Local Court at an early point in time. The matter could have been dealt with in the Local Court but the Crown chose to have the matter dealt with in the District Court.